News
News Release
Cyclomedical Applications Group, LLC
Announces New Associate
Contact: James F. Lamb, Ph.D.
+1-865-670-9021
jlamb@cyclomedical.com
KNOXVILLE, Tennessee,
2003 September 08—Cyclomedical Applications Group is pleased to announce the appointment of another new Associate, expanding the range of accelerator expertise in positron emission tomography (PET) services and capabilities offered to clients.
Dr. Garrett Brown is experienced in radiochemical separations for analytical methods and process chemistry and has produced high-purity radiochemicals for medical purposes. Dr. Brown has assisted various companies in the development of production and quality-control processes and of facilities for production of radiochemical and radioactive medical devices in compliance with USFDA 21 CFR Part 820 Good Manufacturing Practices. His experience includes operating and installing a wide variety of analytical and process instrumentation methods including ion exchange, solvent extraction, gas and liquid chromatography, scintillation counting, dose calibration, gamma energy analysis, mass spectrometry, atomic absorbance, laser welders, sputtering equipment and ultrahigh-vacuum systems as well as training personnel in their use.
Dr. James Lamb, President of Cyclomed, announced, “The addition of Garrett to our group further enhances the range of services that Cyclomed can offer to a PET accelerator owner/operator. Our clients can benefit from the expertise available from a single contractor.”
Cyclomedical Applications Group is an organization of experienced radiopharmaceutical experts serving the radiopharmaceutical industry, especially owners and operators of medical cyclotrons dedicated to the production of positron emitting radioisotopes. It works primarily with facilities producing and distributing F-18 FDG–the most widely used positron-emitting radiopharmaceutical in PET scanning.
Consulting services offered by the company range from short-term consultation to longer-term retainer arrangements and assistance with regulatory agencies as well as cyclotron operation and FDG production problems. Contract management services range from full responsibility for a cyclotron/FDG production facility to a monitoring posture in support of an in-place management team.
Cyclomed’s goal is to provide a full range of support expertise including FDG market research and development, facility financing, facility planning and operation, licensing and safety, and FDA regulatory issues. The company currently has operational responsibility for several cyclotron/FDG facilities and is providing cyclotron consultation services to a number of cyclotron operating companies. For more information, see the Cyclomed web site at www.cyclomedical.com.